Date: Friday, April 29th
Time:1:00 PM EST / 10:00 AM PST
In this webcast TrialCard’s Scott Dulitz explores the importance of speed to therapy as the anchor of a successful HUB program that delivers optimal patient outcomes. Scott examines how top HUB providers leverage technology and systems to quickly navigate the initial steps of a patient’s treatment journey.
Scott Dulitz, MBA, is Vice President of Market Access Solutions, where he is responsible for the product development and strategy of TrialCard’s reimbursement HUB, nursing & adherence, and patient assistance service lines. Mr. Dulitz partners with an internal cross-functional team of IT, operations, client services, and marketing to develop best-in-class patient support programs for TrialCard’s biopharmaceutical clients.
Before Mr. Dulitz joined TrialCard, he worked for Taiho Oncology as Director of Market Access Programs and Professional Relations. There, he led the strategic design and implementation of a limited specialty pharmacy network and patient support program for an oral oncology product. Prior to that role Mr. Dulitz held senior leadership positions in operations, product development, IT, and business development with UBC, an Express Scripts company, and AccessMED, a McKesson Specialty and US Oncology company. During his tenure at UBC and AccessMED Mr. Dulitz developed and managed several innovative, highly visible patient support programs for specialty drugs spanning a variety of therapeutic areas (oncology / hematology, rheumatology, gastroenterology, immunology, nephrology, neurology, pulmonology, endocrinology, transplant, radiopharmaceuticals, and mental health).
Mr. Dulitz has been an invited speaker at many national conferences on market access related topics. He has also authored several articles on distribution and patient support services for specialty drugs.
Mr. Dulitz received his Bachelor of Business Administration in Management Information Systems from Iowa State University and his Masters of Business Administration with an emphasis in finance from the University of Kansas.